Search

everythinglearnresearchcommunity

for

Search:↓

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Type 2 inflammation helps wound healing by switching immune cells to repair mode.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

M2 macrophages, a type of immune cell, help in new hair growth on scars by producing growth factors.

Skin organoids can model tuberculosis infection and help test treatments.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Fat cells help recruit healing cells and build skin structure during wound healing.

Platelet-released growth factors can reduce inflammation in joint disease.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Cells from certain embryo parts can induce head formation in another embryo, involving complex signaling pathways.

Blocking mTORC1 reduces skin tumor growth in mice.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

Placental cell medium boosts blood vessel growth in lab tests.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

miR-26b-5p in macrophage exosomes helps keloids grow.

BFNB could be a promising treatment for hair growth.

Aged individuals heal wounds less effectively due to specific immune cell issues.

BMP signaling controls hair follicle size and cell growth by affecting cell cycle genes.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.